trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Chromosome Inversion D007446 1 associated lipids
Thyroid Hormone Resistance Syndrome D018382 1 associated lipids
Rhabdomyosarcoma, Embryonal D018233 1 associated lipids
Gestational Trophoblastic Disease D031901 1 associated lipids
Carcinoma, Papillary, Follicular D018265 1 associated lipids
Rhabdoid Tumor D018335 1 associated lipids
Visceral Pain D059265 1 associated lipids
Lupus Vulgaris D008177 1 associated lipids
Rubinstein-Taybi Syndrome D012415 1 associated lipids
Goldenhar Syndrome D006053 1 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Bouzelfen A et al. Heterogeneous epigenetic regulation of HACE1 in Burkitt- Lymphoma-derived cells. 2017 Leuk. Res. pmid:28651105
Opiela J et al. In vitro development and cytological quality of inter-species (porcine→bovine) cloned embryos are affected by trichostatin A-dependent epigenomic modulation of adult mesenchymal stem cells. 2017 Theriogenology pmid:28583605
Hou X et al. HDAC inhibitor TSA ameliorates mechanical hypersensitivity and potentiates analgesic effect of morphine in a rat model of bone cancer pain by restoring μ-opioid receptor in spinal cord. 2017 Brain Res. pmid:28559159
Gurgul A et al. The effect of histone deacetylase inhibitor trichostatin A on porcine mesenchymal stem cell transcriptome. 2017 Biochimie pmid:28552396
Yeakley JM et al. A trichostatin A expression signature identified by TempO-Seq targeted whole transcriptome profiling. 2017 PLoS ONE pmid:28542535
Ilicic M et al. Modulation of Progesterone Receptor Isoform Expression in Pregnant Human Myometrium. 2017 Biomed Res Int pmid:28540297
Pandey P et al. Dynamics of post-translationally modified histones during barley pollen embryogenesis in the presence or absence of the epi-drug trichostatin A. 2017 Plant Reprod pmid:28526911
Duan HY et al. Effect of Histone Deacetylase Inhibition on the Expression of Multidrug Resistance-associated Protein 2 in a Human Placental Trophoblast Cell Line. 2017 Chin. Med. J. pmid:28524836
Anantharaju PG et al. Naturally occurring benzoic acid derivatives retard cancer cell growth by inhibiting histone deacetylases (HDAC). 2017 Cancer Biol. Ther. pmid:28506198
Kudo K et al. Biosynthetic Origin of the Hydroxamic Acid Moiety of Trichostatin A: Identification of Unprecedented Enzymatic Machinery Involved in Hydroxylamine Transfer. 2017 J. Am. Chem. Soc. pmid:28497964
Wei W et al. Class I histone deacetylases are major histone decrotonylases: evidence for critical and broad function of histone crotonylation in transcription. 2017 Cell Res. pmid:28497810
Acun T et al. HLJ1 (DNAJB4) Gene Is a Novel Biomarker Candidate in Breast Cancer. 2017 OMICS pmid:28481734
Golfier S et al. High-throughput cell mechanical phenotyping for label-free titration assays of cytoskeletal modifications. 2017 Cytoskeleton (Hoboken) pmid:28445605
Lin W et al. Klotho restoration via acetylation of Peroxisome Proliferation-Activated Receptor γ reduces the progression of chronic kidney disease. 2017 Kidney Int. pmid:28416226
Anderson L et al. Histone deacetylase inhibition modulates histone acetylation at gene promoter regions and affects genome-wide gene transcription in Schistosoma mansoni. 2017 PLoS Negl Trop Dis pmid:28406899
Shao G et al. Inactivation of EGFR/AKT signaling enhances TSA-induced ovarian cancer cell differentiation. 2017 Oncol. Rep. pmid:28393191
Xie C et al. In vitro analysis of factors influencing expression as potential determinants of interindividual variation. 2017 Pharmacol Res Perspect pmid:28357125
Kim YH and Lee JK Histone deacetylase inhibitors suppress immature dendritic cell's migration by regulating CC chemokine receptor 1 expression. 2017 Cell. Immunol. pmid:28341057
Chang YW and Singh KP Long-term exposure to estrogen enhances chemotherapeutic efficacy potentially through epigenetic mechanism in human breast cancer cells. 2017 PLoS ONE pmid:28323900
Ikeda K et al. In vitro drug testing based on contractile activity of C2C12 cells in an epigenetic drug model. 2017 Sci Rep pmid:28300163
Lin S et al. Silencing of ATP4B of ATPase H/K Transporting Beta Subunit by Intragenic Epigenetic Alteration in Human Gastric Cancer Cells. 2017 Oncol. Res. pmid:28281974
Li LF et al. Trichostatin A attenuates ventilation-augmented epithelial-mesenchymal transition in mice with bleomycin-induced acute lung injury by suppressing the Akt pathway. 2017 PLoS ONE pmid:28234968
Wu Y et al. Suppression of Excessive Histone Deacetylases Activity in Diabetic Hearts Attenuates Myocardial Ischemia/Reperfusion Injury via Mitochondria Apoptosis Pathway. 2017 J Diabetes Res pmid:28191472
Trifunović D et al. HDAC inhibition in the cpfl1 mouse protects degenerating cone photoreceptors in vivo. 2016 Hum. Mol. Genet. pmid:28172811
Gilardini Montani MS et al. Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells. 2017 Cell Oncol (Dordr) pmid:28160167
Vanneste M et al. Hyaluronate synthase-2 overexpression alters estrogen dependence and induces histone deacetylase inhibitor-like effects on ER-driven genes in MCF7 breast tumor cells. 2017 Mol. Cell. Endocrinol. pmid:28137613
Wang XJ et al. Opposing Roles of Acetylation and Phosphorylation in LIFR-Dependent Self-Renewal Growth Signaling in Mouse Embryonic Stem Cells. 2017 Cell Rep pmid:28122243
Cao Z et al. TSA and BIX-01294 Induced Normal DNA and Histone Methylation and Increased Protein Expression in Porcine Somatic Cell Nuclear Transfer Embryos. 2017 PLoS ONE pmid:28114389
Chen L et al. PI3K/mTOR dual inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A synergistically exert anti-tumor activity in breast cancer. 2017 Oncotarget pmid:28060760
Hichino A et al. Down-regulation of Claudin-2 Expression and Proliferation by Epigenetic Inhibitors in Human Lung Adenocarcinoma A549 Cells. 2017 J. Biol. Chem. pmid:28057758
Pachano T et al. Epigenetics regulates transcription and pathogenesis in the parasite Trichomonas vaginalis. 2017 Cell. Microbiol. pmid:28054438
Campo VA Comparative effects of histone deacetylases inhibitors and resveratrol on Trypanosoma cruzi replication, differentiation, infectivity and gene expression. 2017 Int J Parasitol Drugs Drug Resist pmid:28038431
Alqinyah M et al. Regulator of G Protein Signaling 10 (Rgs10) Expression Is Transcriptionally Silenced in Activated Microglia by Histone Deacetylase Activity. 2017 Mol. Pharmacol. pmid:28031332
Mazzio EA and Soliman KF HTP Nutraceutical Screening for Histone Deacetylase Inhibitors and Effects of HDACis on Tumor-suppressing miRNAs by Trichostatin A and Grapeseed (Vitis vinifera) in HeLa cells. 2017 Cancer Genomics Proteomics pmid:28031235
Duan H et al. The effect of histone deacetylase inhibition on the expression of P-glycoprotein in human placental trophoblast cell lines. 2017 Placenta pmid:28012453
Choiniere J et al. Pyruvate Dehydrogenase Kinase 4 Deficiency Results in Expedited Cellular Proliferation through E2F1-Mediated Increase of Cyclins. 2017 Mol. Pharmacol. pmid:28003426
Aquea F et al. Chemical inhibition of the histone acetyltransferase activity in Arabidopsis thaliana. 2017 Biochem. Biophys. Res. Commun. pmid:27993678
Mengel A et al. Nitric Oxide Modulates Histone Acetylation at Stress Genes by Inhibition of Histone Deacetylases. 2017 Plant Physiol. pmid:27980017
Takamatsu G et al. Tescalcin is a potential target of class I histone deacetylase inhibitors in neurons. 2017 Biochem. Biophys. Res. Commun. pmid:27939885
Cipriano M et al. The role of epigenetic modifiers in extended cultures of functional hepatocyte-like cells derived from human neonatal mesenchymal stem cells. 2017 Arch. Toxicol. pmid:27909741
Bricambert J et al. Impaired histone deacetylases 5 and 6 expression mimics the effects of obesity and hypoxia on adipocyte function. 2016 Mol Metab pmid:27900262
Jia L et al. Trichostatin A increases radiosensitization of tongue squamous cell carcinoma via miR‑375. 2017 Oncol. Rep. pmid:27878285
Deng Z et al. Histone Deacetylase Inhibitor Trichostatin a Promotes the Apoptosis of Osteosarcoma Cells through p53 Signaling Pathway Activation. 2016 Int. J. Biol. Sci. pmid:27877082
Huynh NC et al. Histone deacetylase inhibition enhances in-vivo bone regeneration induced by human periodontal ligament cells. 2017 Bone pmid:27871909
Kim HR et al. Aberrant Expression of TIMP-2 and PBEF Genes in the Placentae of Cloned Mice Due to Epigenetic Reprogramming Error. 2016 PLoS ONE pmid:27855185
Choi SA et al. A novel histone deacetylase inhibitor, CKD5, has potent anti-cancer effects in glioblastoma. 2017 Oncotarget pmid:27852054
Tombolan L et al. Global DNA methylation profiling uncovers distinct methylation patterns of protocadherin alpha4 in metastatic and non-metastatic rhabdomyosarcoma. 2016 BMC Cancer pmid:27842508
Zapletal O et al. Butyrate alters expression of cytochrome P450 1A1 and metabolism of benzo[a]pyrene via its histone deacetylase activity in colon epithelial cell models. 2017 Arch. Toxicol. pmid:27830268
Bauer I et al. A Class 1 Histone Deacetylase with Potential as an Antifungal Target. 2016 MBio pmid:27803184
Staberg M et al. Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine. 2017 Cell Oncol (Dordr) pmid:27766591